What Andy Warhol Can Teach Us About Maximizing Trading Profits
Oct 08, 2017
Jeremy Parkinson
Finance
Three weeks after comparing fund managers who lose money for their clients by desperately clinging to hypotheses about how the world should work (as opposed to how it actually does work) to the Cassini spacecraft (which careened into Saturn’s atmosphere at about 78,000 mph last month), Bloomberg’s Cameron Crise is back with some more “deep” macro thoughts for you. See if you’re […]
Forex Forecast: Pairs In Focus – Oct. 8
Oct 08, 2017
Jeremy Parkinson
Finance
The difference between success and failure in Forex trading is very likely to depend upon which currency pairs you choose to trade each week, and not on the exact trading methods you might use to determine trade entries and exits. Each week I am going to analyze fundamentals, sentiment and technical positions in order to […]
USD/JPY Outlook Clouded With Mixed Signals Ahead Of FOMC Minutes
Oct 08, 2017
Jeremy Parkinson
Finance
Fundamental Forecast for Japanese Yen: Bearish USD/JPY appears to be on its way to test the July-high (114.50) as it clears the monthly opening range following the U.S. Non-Farm Payrolls (NFP) report, but the near-term outlook remains clouded with mixed signals as the rebound from the 2017-low (107.32) appears to be losing momentum. Even though U.S. […]
Why A New Form Of ‘Nationalization’ Will Occur
Oct 08, 2017
Jeremy Parkinson
Finance
The extended period of Quantitative Easing (QE) and ZIRP have now left the major global central bankers in an untenable position because of the era of unlimited leverage which it has fostered. According to the Bank for International Settlements, central banks’ combined asset holdings in the major advanced economies (the US, the Eurozone, and Japan) […]
Breakout – Value Line Geometric Index
Oct 08, 2017
Jeremy Parkinson
Finance
The Value Line Geometric Index ($XVG) is an equal weighting of all the stocks on the NYSE. It has been consolidating sideways for almost 20 years. In the last several months it has broken out to the upside. This suggests a powerful and sustained move higher in the stock markets is likely to take place, […]
Weekly Sentiment Survey: Bond Bears And Equity Bulls
Oct 08, 2017
Jeremy Parkinson
Finance
This article reviews the data from the latest weekly sentiment survey we conduct over on Twitter. The survey measures respondents’ equity and bond positioning/view – differentiating between whether the view is bullish or bearish for technical or fundamental reasoning. The latest results were more or less in line with that of last week’s and the main takeaway in that […]
The Great Disconnect: 5 Reasons Why Volatility Is Detached From ‘Chaotic Uncertainty’
Oct 08, 2017
Jeremy Parkinson
Finance
Listen: we live an uncertain world. And part of that uncertainty is directly attributable to the increasingly cartoonish cast of the characters upon whose dispositions our fate depends. We gave you a brief overview of what we’ve called “The Austin Powers World” earlier on Sunday. In short, the geopolitical scene is a fusion of a James […]
Trading Support And Resistance – Oct. 8
Oct 08, 2017
Jeremy Parkinson
Finance
This week we’ll begin with our monthly and weekly forecasts of the currency pairs worth watching. The first part of our forecast is based upon our research of the past 16 years of Forex prices, which show that the following methodologies have all produced profitable results: Trading the two currencies that are trending the most strongly over the […]
Bitcoin Surges Back Above $4600 For The First Time In A Month
Oct 08, 2017
Jeremy Parkinson
Finance
Bitcoin continues to march back towards its record highs, breaking back above $4600 for the first time since September 8. So what will it take for the digital currency to get back to record highs above $5000 and beyond? Forbes’ Panos Mourdoukoutas offers several possible catalysts… The return of buzz, which will bring buyers back to the […]
Here’s What’s Has Happened In The HCV Space Lately
Oct 08, 2017
Jeremy Parkinson
Finance
Hepatitis C is an infectious disease caused by the hepatitis C virus (HCV) that primarily affects the liver. Gilead Sciences Inc. (GILD – Free Report) markets blockbuster HCV drugs, Sovaldi and Harvoni, while other well-known names in this market are AbbVie Inc.’s (ABBV – Free Report) Viekira Pak, Bristol-Myers’ (BMY – Free Report) Daklinza and Johnson & Johnson’s (JNJ – Free Report) Olysio. […]